➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: June 12, 2021

DrugPatentWatch Database Preview


Email this page to a colleague

« Back to Dashboard

When do Zidovudine patents expire, and when can generic versions of Zidovudine launch?

Zidovudine is a drug marketed by Aurobindo Pharma Ltd, Cipla Ltd, Am Regent, Liaoning Chengda, Aurobindo, Aurobindo Pharma, Cipla, Hec Pharm, Hetero Labs Ltd Iii, Hikma, Mylan Labs Ltd, Mylan Pharms Inc, and Ranbaxy Labs Ltd. and is included in fifteen NDAs.

The generic ingredient in ZIDOVUDINE is zidovudine. There are twenty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the zidovudine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zidovudine

A generic version of ZIDOVUDINE was approved as zidovudine by AUROBINDO on September 19th, 2005.

  Get Started Free

Drug patent expirations by year for ZIDOVUDINE
Drug Prices for ZIDOVUDINE

See drug prices for ZIDOVUDINE

Recent Clinical Trials for ZIDOVUDINE

Identify potential brand extensions & 505(b)(2) entrants

Augusta UniversityPhase 4
University of Cape TownPhase 4
Infectious Diseases Institute, UgandaPhase 3

See all ZIDOVUDINE clinical trials

Medical Subject Heading (MeSH) Categories for ZIDOVUDINE

US Patents and Regulatory Information for ZIDOVUDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ZIDOVUDINE zidovudine CAPSULE;ORAL 078128-001 Mar 27, 2006 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo ZIDOVUDINE zidovudine TABLET;ORAL 077267-001 Sep 19, 2005 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Liaoning Chengda ZIDOVUDINE zidovudine INJECTABLE;INJECTION 204538-001 Nov 26, 2013 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Hikma ZIDOVUDINE zidovudine TABLET;ORAL 076844-001 Sep 19, 2005 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.